logo

Syncom Formulation (India) Ltd. Financials

15:58 Jun 18

Syncom Formulation (India) Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
19.27
-1.00 (-4.93%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Syncom Formulation (India) Ltd. Financials

Syncom Formulation (India) Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
19.27
-1.00 (-4.93%)
15:58 Jun 18
Quality
image/svg+xml

86/100
High Financial Strength

Valuation
image/svg+xml

40/100
Mid Valuation

Technical

48/100
Technically Neutral

Strength

13

Weakness

3

Opportunity

0

Threats

0

14.44 %

ROE %

11.96 %

ROA %

0.53

EPS

3.64

BVPS

10.63 %

Net Profit Margin

Mar 2017 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
184.82 219.66 224.25 263.39 465.01
Operating Expenses +
168.33 199.62 204.62 233.75 410.89
Raw Material
123.14 137.22 142.07 158.64 318
Increase Decrease in Cost
4.97 3.32 -0.38 -1.75 -10.66
Other Manufacturing Expense
4.29 6.31 8.15 8.12 0
Employee Cost
14.62 22.16 25.87 35.06 52.17
Miscellaneous Expenses
129.55 110.23 114.13 87.9 131.32
Operating Profit
16.49 20.04 19.63 29.64 54.12
Other Income
2.79 11.99 14.6 13.53 17.43
Depreciation
3.12 3.95 4.54 4.72 5.19
Interest
0.28 1.93 3.13 4.47 0.86
Profit before tax and exceptio..
15.89 26.15 26.56 33.98 65.51
Exceptional Items
0 0.02 0.01 -0.02 0.01
PBT
15.89 26.18 26.57 33.95 65.51
Provision for Taxation
5.34 6.39 6.5 8.64 16.08
Net Profit
10.53 19.79 20.07 25.31 49.43
NET Profit after MI
10.53 19.79 20.07 25.31 49.43
EPS
0.13 0.26 0.24 0.34 0.57
Operating Profit Margin (%)
8.92 9.12 8.75 11.25 11.64
Net Profit Margin (%)
5.7 9.01 8.95 9.61 10.63

Syncom Formulation (India) Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 50.60 50.60 50.60 50.60 50.60
FII 0.10 0.10 0.10 0.10 0.10
MF 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 -0.10
Shareholder Shares Holding %
Research 360 logo
Download Our App On: